ICD-10-CM Diagnosis Code G72.9 - Myopathy, unspecified (original) (raw)

ICD List Logo

ICD List 2025-2026 Edition

  1. Home
  2. ICD-10-CM Codes
  3. G00–G99
  4. G70-G73
  5. G72
  6. 2026 ICD-10-CM Code G72.9

Myopathy, unspecified

ICD-10-CM Code:

G72.9

ICD-10 Code for:

Myopathy, unspecified

Is Billable?

Yes - Valid for Submission

Chronic Condition Indicator: [1]

Not chronic

Code Navigator:

G72.9 is a billable diagnosis code used to specify a medical diagnosis of myopathy, unspecified. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2025 through September 30, 2026.

Unspecified diagnosis codes like G72.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.

  1. Code Information
  2. Approximate Synonyms
  3. Clinical Classification
  4. Clinical Information
  5. Tabular List of Diseases and Injuries
  6. Index to Diseases and Injuries References
  8. Convert to ICD-9 Code
  9. Patient Education
  10. Other Codes Used Similar Conditions
  11. Code History

The following list of clinical terms are approximate synonyms, alternative descriptions, or common phrases that might be used by patients, healthcare providers, or medical coders to describe the same condition. These synonyms and related diagnosis terms are often used when searching for an ICD-10 code, especially when the exact medical terminology is unclear. Whether you're looking for lay terms, similar diagnosis names, or common language alternatives, this list can help guide you to the correct ICD-10 classification.

Clinical Classifications group individual ICD-10-CM diagnosis codes into broader, clinically meaningful categories. These categories help simplify complex data by organizing related conditions under common clinical themes.

They are especially useful for data analysis, reporting, and clinical decision-making. Even when diagnosis codes differ, similar conditions can be grouped together based on their clinical relevance. Each category is assigned a unique CCSR code that represents a specific clinical concept, often tied to a body system or medical specialty.

CCSR Code: NVS018

Inpatient Default: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.

Outpatient Default: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.

an autosomal recessive subtype of 3-methylglutaconic aciduria caused by mutation(s) in the dnajc19 gene, encoding mitochondrial import inner membrane translocase subunit tim14.

human acta1 wild-type allele is located in the vicinity of 1q42.13 and is approximately 4 kb in length. this allele, which encodes actin, alpha skeletal muscle protein, is involved in sarcomere formation and contractile activity. mutation of the gene is associated with scapulohumeroperoneal myopathy, nemaline myopathy 3, congenital myopathy with excess of thin myofilaments, congenital myopathy with cores, and congenital myopathy with fiber-type disproportion 1.

a dilated cardiomyopathy which is associated with consumption of large amounts of alcohol over a period of years.

a reversible cardiomyopathy presumed to result from the presence of arrhythmias, including the tachycardia-induced cardiomyopathy (t-cm), atrial fibrillation-induced cardiomyopathy (af-cm), and premature ventricular contraction-induced cardiomyopathy (pvc-cm).

a rare genetic disorder characterized by cardiomyopathy affecting the right ventricle. the heart tissue is replaced by fibrous and adipose tissues. it is characterized by ventricular arrhythmia and right ventricular dysfunction. it is a cause of sudden death.

a usually autosomal dominant inherited movement disorder caused by mutations in the col6a1, col6a2, and col6a3 genes. it is characterized by progressive muscle weakness and joint stiffness in the fingers, wrists, elbows, and ankles.

a dilated cardiomyopathy caused by the protozoan trypanosoma cruzi. patients may present with heart block, congestive heart failure, or anginal symptoms.

a disease of the heart muscle or myocardium proper. cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.

an autosomal dominant congenital disorder affecting the skeletal muscles. microscopically, it is characterized by disorganized areas, which are called cores, seen usually in the center of the muscle fibers. clinically it presents as mild to severe muscle weakness. it may be associated with skeletal abnormalities including scoliosis, joint deformities, and hip dislocation.

a myopathy inherited in an autosomal dominant or recessive pattern, caused by mutations in the dnm2, bin1, and ttn genes. microscopically there is central displacement of the nucleus in muscle cells. it is characterized by muscle weakness and atrophy in the skeletal muscles.

a hamartomatous lesion of the sinoatrial node, atrioventricular node, and purkinje fibers of the cardiac conducting system. it occurs predominantly in the first two years of life. most patients present with arrhythmias and electrical disturbances. it is characterized by the presence of multifocal, poorly defined islands of large polygonal cells with a granular eosinophilic cytoplasm, a small round to oval-shaped nucleus, and occasional nucleoli. the cytoplasmic appearance is due to extensive accumulation of mitochondria. if left untreated, this condition is usually fatal. however, the outcome has improved over the past two decades due to developments in surgical intervention, electrophysiological mapping, and ablation of the arrhythmogenic foci, with a survival rate of approximately 80%. (who 2015)

a rare genetic disorder caused by mutations in the tpm3, acta1, ryr1 and sepn1 genes. it is inherited in an autosomal dominant or recessive pattern and rarely in an x-linked pattern. it manifests with myopathy throughout the body, particularly in the muscles of the shoulders, upper arms, hips, and thighs. affected individuals may have contractures, lordosis, or scoliosis. in a minority of cases mild to severe breathing problems may occur.

a group of rare genetic muscle disorders characterized by hypotonia, muscle weakness, and delayed development of motor skills.

acute muscle weakness and paralysis that develops in critically ill patients who have been treated with multiple drugs during their intensive care unit stay. it is associated with delayed weaning from mechanical ventilation and prolonged rehabilitation.

polyneuropathy and myopathy arising in intensive care unit patients.

evidence of dermatopolymyositis, unspecified with myopathy.

evidence of dermatopolymyositis, unspecified without myopathy.

cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. it may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. it is a cause of congestive heart failure.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the lmna gene, encoding lamin-a and lamin c.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the ldb3 gene, encoding lim domain-binding protein 3.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the tnnt2 gene, encoding troponin t, cardiac muscle.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the rbm20 gene, encoding rna-binding protein 20.

a subtype of dilated cardiomyopathy caused by mutation(s) in the ttn gene, encoding titin.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the bag3 gene, encoding bag family molecular chaperone regulator 3.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the pln gene, encoding cardiac phospholamban.

an genetic condition that is a subtype of dilated cardiomyopathy caused by mutation(s) in the vcl gene, encoding vinculin.

an autosomal recessive subtype of dilated cardiomyopathy caused by mutation(s) in the ppcs gene, encoding phosphopantothenate--cysteine ligase.

an autosomal dominant condition caused by mutation(s) in the lmna gene, encoding prelamin-a/c. it is characterized by dilated cardiomyopathy and hypergonadotropic hypogonadism.

a group of genetic degenerative muscle disorders affecting the muscles of the lower arms, hands, lower legs, and feet.

a rare autosomal dominant disorder caused by mutations in the cnbp gene. it is characterized by muscle pain, fatigue, and weakness of the proximal muscles of the lower extremities.

an autosomal dominant arrhythmogenic cardiomyopathy caused by mutations(s) in the tmem43 gene on chromosome 3p25, encoding transmembrane protein 43. it is characterized by ventricular ectopy, left ventricular dilation, heart failure, and early death.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the cav3 gene, myh7 gene, or mylk2 gene encoding caveolin-3, myosin heavy chain 7, and myosin light chain kinase 2, skeletal/cardiac muscle respectively.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the actc1 gene, encoding actin, alpha cardiac muscle 1.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the myh6 gene, encoding myosin-6.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the jph2 gene, encoding junctophilin-2.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the tnnt2 gene, encoding troponin t, cardiac muscle.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the flnc gene, encoding filamin-c.

an autosomal recessive subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the alpk3 gene, encoding alpha-protein kinase 3.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the tpm1 gene, encoding tropomyosin alpha-1 chain.

an autosomal dominant condition caused by mutation(s) in the mybpc3 gene, encoding mybpc3 protein. it is characterized by severe neonatal hypertrophic cardiomyopathy.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the prkag2 gene, encoding 5'-amp-activated protein kinase subunit gamma-2.

an autosomal dominant subtype of familial hypertrophic cardiomyopathy caused by mutation(s) in the tnni3 gene, encoding troponin i, cardiac muscle.

hypertrophic cardiomyopathy caused by mutations in the genes encoding components of the sarcomere, in the absence of predisposing conditions.

an autosomal dominant condition caused by mutation(s) in the flnc gene, encoding filamin-c. it is characterized by restrictive cardiomyopathy in the context of normal contractility, left ventricular wall thickness and systolic function.

a history of a first-degree relative that was diagnosed with cardiomyopathy.

imaging findings only

symptomatic without signs of heart failure

symptomatic heart failure or other cardiac symptoms, responsive to intervention; new onset of symptoms

refractory heart failure or other poorly controlled cardiac symptoms

death

transthyretin amyloid cardiomyopathy caused by mutation(s) in the ttr gene, encoding transthyretin.

a condition in which the myocardium is hypertrophied without an obvious cause. the hypertrophy is generally asymmetric and may be associated with obstruction of the ventricular outflow tract.

a disease of the heart muscle or myocardium proper whose cause is unknown.

an umbrella term for diseases which have chronic muscle inflammation and weakness of unknown etiology. the types of idiopathic inflammatory myopathy are further defined by either clinicopathologic criteria or by the presence of certain autoantibodies.

a rare autosomal dominant inherited disorder caused by mutations in the vcp gene. it can affect the muscles, bones, and brain. patients may develop myopathy that initially involves the muscles of the hips and shoulders and as the disorder progresses it may affect the cardiac and respiratory muscles, leading to life-threatening cardiac and pulmonary failure. approximately half of the adults develop paget disease of bone, and approximately one-third develop frontotemporal dementia.

an autosomal dominant condition caused by mutation(s) in the klhl24 gene, encoding kelch-like protein 24. it is characterized by epidermolysis bullosa and dilated cardiomyopathy.

reduced left ventricular function with less than 50% ejection fraction in a patient with history of suspected or confirmed myocardial ischemia or acute coronary syndrome (acs) that started during probable or confirmed acute covid-19 and persisted beyond four weeks after the initial diagnosis of covid-19.

a rare form of juvenile dermatomyositis that manifests with characteristic cutaneous findings for at least six months in the absence of any detectable muscle involvement.

evidence of juvenile dermatomyositis with myopathy.

an uncommon congenital abnormality where the left ventricular myocardium fails to compact during embryonic development, leading to cardiomyopathy with a variable degree of ventricular dysfunction. there is genetic heterogeneity and phenotypic variability. characteristically, there are typically deep trabeculations in the noncompacted area, with varying proportions of the lv myocardium compacted. lv noncompaction is associated with rhythm abnormalities including wolff-parkinson-white syndrome, conduction defects, and ventricular tachyarrhythmias.

human lmna wild-type allele is located within 1q22 and is approximately 25 kb in length. this allele, which encodes prelamin-a/c protein, plays a role in nuclear stability and chromatin structure. mutations in the lmna gene are associated with charcot-marie-tooth disease, type 2b1, hutchinson-gilford progeria syndrome, emery-dreifuss muscular dystrophy, malouf syndrome, autosomal dominant familial partial lipodystrophy type 2, lethal restrictive dermopathy, autosomal dominant limb girdle muscular dystrophy 1b and autosomal dominant dilated cardiomyopathy 1a..

a rare progressive neurodegenerative disorder characterized by mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

a group of rare inherited disorders characterized by a deficiency of enzymes that are involved in metabolic pathways that affect muscles. the disorders are characterized by muscle dysfunction.

an autosomal recessive condition caused by mutation(s) in the ryr1 gene, encoding ryanodine receptor 1. it may be characterized clinically by neonatal hypotonia, delayed motor development, and generalized muscle weakness, and amyotrophy. pathologically, the absence of mitochondria and focal disorganization of the sarcomere appear as "minicores" on atpase staining as a result of focal defects in oxidative activity.

myopathy caused by mitochondrial abnormalities.

a muscular dystrophy or storage disease that causes cardiomyopathy.

human myh6 wild-type allele is located in the vicinity of 14q11.2 and is approximately 26 kb in length. this allele, which encodes myosin-6 protein, plays a role in atrial muscle cell contraction. mutation of the gene is associated with atrial septal defect 3, sick sinus syndrome 3, dilated cardiomyopathy 1ee and hypertrophic cardiomyopathy 14.

an inherited or sporadic disorder affecting the skeletal muscles.

myomegalin (2346 aa, ~265 kda) is encoded by the human pde4dip gene. this protein plays a role in the localization of phosphodiesterase 4d.

a non-neoplastic disorder that affects the muscles. representative examples include muscular dystrophy, metabolic myopathies, muscular atrophies, and dermatomyositis.

an autosomal recessive condition caused by mutation(s) in the ampd1 gene, encoding amp deaminase 1. the condition is characterized by exercise-induced muscle pain and/or fatigue, which may be associated with rhabdomyolysis and/or increased concentrations of creatinine kinase.

a myopathy that was caused by a primary disorder of fatty acid oxidation.

a myopathy that was caused by a primary disorder of glycogen storage.

an autosomal recessive inherited myopathy caused by mutations in the neb gene. it is characterized by generalized hypotonia and skeletal muscle weakness.

an inherited myopathy caused by mutations in the acta1 gene, encoding actin, alpha skeletal muscle. the phenotype is highly variable, and as such attempts at classification by clinical features is not optimal. generally, affected individuals have generalized muscle weakness, typically involving proximal muscles, the face, bulbar and respiratory muscles.

an autosomal dominant myopathy caused by mutation(s) in the tpm2 gene, encoding tropomyosin beta chain. classification of nemaline myopathies by clinical features is not optimal, as the phenotypes are highly variable.

an autosomal recessive myopathy caused by mutations in the klhl40 gene, encoding kelch-like protein 40. the phenotype is highly variable, and as such attempts at classification by clinical features is not optimal. generally, affected individuals have generalized muscle weakness, and typically involves proximal muscles, the face, bulbar and respiratory muscles.

an indication that the patient does not have a history of myopathy.

an autosomal recessive condition caused by mutation(s) in the gne gene, encoding bifunctional udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase. it is characterized by distal muscle weakness and atrophy, especially the tibialis anterior, and sparing of the quadriceps.

reduced left ventricular function with less than 50% ejection fraction but without evidence of myocardial ischemia that started during probable or confirmed acute covid-19 and persisted beyond four weeks after the initial diagnosis of covid-19.

an autosomal dominant condition caused by mutation(s) in the gipc1 gene, encoding pdz domain-containing protein gipc1. it is characterized by distal muscle weakness and ophthalmoplegia, with a slowly progressive course.

evidence of other dermatomyositis with myopathy not specified elsewhere.

evidence of other dermatomyositis without myopathy not specified elsewhere.

evidence of paraneoplastic neuromyopathy and neuropathy.

human pde4dip wild-type allele is located in the vicinity of 1q12 and is approximately 240 kb in length. this allele, which encodes myomegalin protein, is involved in the localization of phosphodiesterase activity. a chromosomal translocation t(1;5)(q23;q33) of this gene and the pdgfrb gene is associated with myeloproliferative disorder associated with eosinophilia.

a condition presenting toward the end of pregnancy or in the months following delivery characterized by left ventricular dysfunction. the nhlbi introduced the metric of left ventricular ejection fraction of less than 45 percent in 1999. microrna-146a has been cited as a potential biomarker for ppcm.

evidence of polymyositis with myopathy.

a spontaneous muscular disease in minipigs, characterized by changes in skeletal myofibers, including both acute (dominated by necrosis, hemorrhage, edema, and mixed inflammatory cell infiltrates) and more chronic lesions (characterized by basophilic regenerating myofibers, mineralization, and occasionally fibrosis). (inhand)

a disorder characterized by an inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and loses its flexibility.

a type of heart disorder referring to the inability of the ventricles to fill with blood because the myocardium (heart muscle) stiffens and looses its flexibility. causes include replacement of the myocardium with scar tissue, abnormal cellular infiltration of the myocardium, or deposition of a substance (e.g., amyloid) in the myocardium.

evidence of rheumatoid myopathy with rheumatoid arthritis of left ankle and foot.

evidence of rheumatoid myopathy with rheumatoid arthritis of left elbow.

evidence of rheumatoid myopathy with rheumatoid arthritis of left hand.

evidence of rheumatoid myopathy with rheumatoid arthritis of left hip.

evidence of rheumatoid myopathy with rheumatoid arthritis of left knee.

evidence of rheumatoid myopathy with rheumatoid arthritis of left shoulder.

evidence of rheumatoid myopathy with rheumatoid arthritis of left wrist.

evidence of rheumatoid myopathy with rheumatoid arthritis of multiple sites.

evidence of rheumatoid myopathy with rheumatoid arthritis of right ankle and foot.

evidence of rheumatoid myopathy with rheumatoid arthritis of right elbow.

evidence of rheumatoid myopathy with rheumatoid arthritis of right hand.

evidence of rheumatoid myopathy with rheumatoid arthritis of right hip.

evidence of rheumatoid myopathy with rheumatoid arthritis of right knee.

evidence of rheumatoid myopathy with rheumatoid arthritis of right shoulder.

evidence of rheumatoid myopathy with rheumatoid arthritis of right wrist.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified ankle and foot.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified elbow.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified hand.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified hip.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified knee.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified shoulder.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified site.

evidence of rheumatoid myopathy with rheumatoid arthritis of unspecified wrist.

a spontaneous, age-related cardiac disease of rats and mice, characterized by myocardial changes presenting a continuum that begins as focal to multifocal individual cardiomyocyte necrosis attended by a few inflammatory cells progressing at different rates in different animals to include multifocal mononuclear cell inflammation and even fibrosis for larger lesions. (inhand)

evidence of sicca syndrome with myopathy.

a non-neoplastic disorder affecting the skeletal muscles. it is caused by damage to muscle fibers either by excessive intake of corticosteroids (steroid treatment) or high levels of endogenous corticosteroids due to hormonal abnormalities. patients usually present with weakness mainly in the proximal muscles of the upper and lower extremities and the neck flexors.

evidence of systemic sclerosis with myopathy.

human tafazzin wild-type allele is located in the vicinity of xq28 and is approximately 10 kb in length. this allele, which encodes tafazzin protein, plays a role in phospholipid metabolism, including cardiolipin remodeling. mutations in the gene are associated with barth syndrome, dilated cardiomyopathy (dcm), hypertrophic dcm, endocardial fibroelastosis and left ventricular noncompaction.

a rare disorder characterized by transient left ventricular wall systolic dysfunction, resulting in apical ballooning appearance, chest pain, and st segment elevation.

human tnnt2 wild-type allele is located in the vicinity of 1q32 and is approximately 19 kb in length. this allele, which encodes troponin t, cardiac muscle, is involved in muscle contraction.

human tpm1 wild-type allele is located in the vicinity of 15q22.1 and is approximately 29 kb in length. this allele, which encodes tropomyosin alpha-1 chain protein, is involved in the regulation of muscle contraction. mutation of the gene is associated with left ventricular non-compaction 9 and cardiomyopathy types familial hypertrophic 3 and dilated 1y.

human tpm2 wild-type allele is located in the vicinity of 9p13 and is approximately 9 kb in length. this allele, which encodes tropomyosin beta chain protein, is involved in muscle contraction. mutation of the gene is associated with nemaline myopathy type 4, cap myopathy type 2 and distal arthrogryposis types 1a and 2b.

cardiomyopathy resulting from the deposition of misfolded transthyretin. the condition can be classified by the presence (hereditary transthyretin amyloid) or absence (wild-type transthyretin amyloid) of mutation(s) in the ttr gene, encoding transthyretin.

human ttn wild-type allele is located in the vicinity of 2q31 and is approximately 305 kb in length. this allele, which encodes titin protein, is involved in both muscle filament structure and protein phosphorylation. mutation of the gene is associated with hereditary myopathy with early respiratory failure, familial hypertrophic cardiomyopathy type 9, cardiomyopathy dilated type 1g, tardive tibial muscular dystrophy, limb-girdle muscular dystrophy type 2j and early-onset myopathy with fatal cardiomyopathy.

an indication that it is unknown whether the patient has a history of myopathy.

an x-linked recessive inherited disorder caused by mutations in the mtm1 gene. primarily it affects males. female carriers are usually asymptomatic. it is characterized by skeletal muscle weakness and hypotonia. the muscle weakness ranges from mild to severe. newborns with severe x-linked centronuclear myopathy develop respiratory distress which may lead to respiratory failure requiring constant ventilator assistance. patients with mild x-linked centronuclear myopathy usually require ventilator support during the newborn period only.

an autosomal dominant condition caused by mutation(s) in the ryr1 gene, encoding ryanodine receptor 1. the phenotype is variable, but generally includes weakness in the proximal muscles of the lower limb and individuals are at increased risk for malignant hyperthermia.

an autosomal dominant form of congenital myopathy caused by mutation(s) in the myh7 gene, encoding myosin-7.

an autosomal dominant subtype of dilated cardiomyopathy caused by mutation(s) in the cryab gene, encoding alpha-crystallin b chain.

an autosomal dominant condition caused by mutation(s) in the adss1 gene, encoding adenylosuccinate synthetase isozyme 1. it is characterized by adolescent onset of distal muscular weakness primarily affecting the lower limbs.

the accumulation of attr amyloid deposits in the heart due to mutations in the ttr gene.

a subgrouping of the inflammatory myopathies characterized by severe proximal weakness, elevated creatine kinase levels, and myofiber necrosis. they can be further distinguished by the presence or absence of associated autoantibodies, including anti-3-hydroxy-3-methylglutaryl-coa reductase (hmgcr), anti-signal recognition particle (srp), and antibody negative immune-mediated necrotizing myopathy (imnm).

human klhl40 wild-type allele is located in the vicinity of 3p22.1 and is approximately 7 kb in length. this allele, which encodes kelch-like protein 40, is involved in targeting proteins for ubiquitination and degradation. mutation of the gene is associated with nemaline myopathy 8.

human ldb3 wild-type allele is located in the vicinity of 10q23.2 and is approximately 69 kb in length. this allele, which encodes lim domain-binding protein 3, plays a role in maintaining the structural integrity of the z-discs in striated muscle. mutation of the gene is associated with dilated cardiomyopathy 1c, hypertrophic cardiomyopathy 24, left ventricular noncompaction 3 and myofibrillar myopathy 4.

human mtm1 wild-type allele is located in the vicinity of xq28 and is approximately 110 kb in length. this allele, which encodes myotubularin protein, is involved in the dephosphorylation of phospholipids. mutations in the gene are associated with x-linked centronuclear myopathy.

a subtype of myofibrillar myopathy caused by mutations in the des gene, encoding desmin.

an autosomal dominant subtype of myofibrillar myopathy caused by mutation(s) in the cryab gene, encoding alpha-crystallin b chain.

an autosomal dominant subtype of myofibrillar myopathy caused by mutation(s) in the myot gene, encoding myotilin.

an autosomal dominant subtype of myofibrillar myopathy caused by mutation(s) in the flnc gene, encoding filamin-c.

human neb wild-type allele is located in the vicinity of 2q23.3 and is approximately 249 kb in length. this allele, which encodes nebulin protein, plays a role in muscle cell development and sarcomere maintenance. mutations in the gene are associated with arthrogryposis multiplex congenita 6 and autosomal recessive nemaline myopathy 2.

human tnnt2 wild-type allele is located in the vicinity of 1q32.1 and is approximately 19 kb in length. this allele, which encodes troponin t, cardiac muscle, is involved in muscle contraction.

an autosomal dominant type of functional intestinal obstruction caused by mutation(s) in the actg2 gene, encoding actin, gamma-enteric smooth muscle.

an x-linked dominant condition caused by mutation(s) in the fhl1 gene, encoding four and a half lim domains protein 1. it is characterized by weakness in the shoulder-girdle and peroneal muscles.

a rare, non-progressive congenital disorder characterized by multiple joint contractures which are present at birth.

an idiopathic inflammatory myopathy that occurs during childhood.

dilated cardiomyopathy inherited in an autosomal dominant pattern caused by mutation(s) in the scn5a gene, encoding sodium channel protein type 5 subunit alpha.

an umbrella term for diseases which have chronic muscle inflammation and weakness of unknown etiology. the types of idiopathic inflammatory myopathy are further defined by either clinicopathologic criteria or by the presence of certain autoantibodies.

human myh7 wild-type allele is located in the vicinity of 14q11.2 and is approximately 23 kb in length. this allele, which encodes myosin-7 protein, plays a role in thick filament formation and muscle contraction. mutations in the gene are associated with dilated cardiomyopathy 1s (left ventricular noncompaction 5), hypertrophic cardiomyopathy 1, laing distal myopathy, and myosin storage congenital myopathy types 7a (autosomal dominant) and 7b (autosomal recessive).

an autosomal dominant subtype of myofibrillar myopathy caused by mutation(s) in the bag3 gene, encoding bag family molecular chaperone regulator 3.

an autosomal recessive condition caused by mutation(s) in the shmt2 gene, encoding serine hydroxymethyltransferase, mitochondrial. it is characterized by global neurodevelopmental delay, severely impaired intellectual development, poor overall growth, and spasticity of the lower limbs. most affected individuals also have progressive hypertrophic cardiomyopathy in childhood or cardiac developmental anomalies.

dilated cardiomyopathy secondary to exposure to a toxin.

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

References found for this diagnosis code in the External Cause of Injuries Index:

Below are the ICD-9 codes that most closely match this ICD-10 code, based on the General Equivalence Mappings (GEMs). This ICD-10 to ICD-9 crosswalk tool is helpful for coders who need to reference legacy diagnosis codes for audits, historical claims, or approximate code comparisons.

ICD-9-CM: 359.9

Approximate Flag - The approximate mapping means this ICD-10 code does not have an exact ICD-9 equivalent. The matched code is the closest available option, but it may not fully capture the original diagnosis or clinical intent.

Muscle Disorders

Your muscles help you move and help your body work. Different types of muscles have different jobs. There are many problems that can affect muscles. Muscle disorders can cause weakness, pain or even paralysis.

Causes of muscle disorders include:

Sometimes the cause of muscle disorders is unknown.

[Learn More in MedlinePlus]